Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.

Li B, Brady SW, Ma X, Shen S, Zhang Y, Li Y, Szlachta K, Dong L, Liu Y, Yang F, Wang N, Flasch DA, Myers MA, Mulder HL, Ding L, Liu Y, Tian L, Hagiwara K, Xu K, Zhou X, Sioson E, Wang T, Yang L, Zhao J, Zhang H, Shao Y, Sun H, Sun L, Cai J, Sun HY, Lin TN, Du L, Li H, Rusch M, Edmonson MN, Easton J, Zhu X, Zhang J, Cheng C, Raphael BR, Tang J, Downing JR, Alexandrov LB, Zhou BS, Pui CH, Yang JJ, Zhang J.

Blood. 2019 Oct 24. pii: blood.2019002220. doi: 10.1182/blood.2019002220. [Epub ahead of print]

PMID:
31697823
2.
3.

Time series analysis of human brucellosis in mainland China by using Elman and Jordan recurrent neural networks.

Wu W, An SY, Guan P, Huang DS, Zhou BS.

BMC Infect Dis. 2019 May 14;19(1):414. doi: 10.1186/s12879-019-4028-x.

4.

Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia.

Chen YL, Tang C, Zhang MY, Huang WL, Xu Y, Sun HY, Yang F, Song LL, Wang H, Mu LL, Li MH, Zheng WW, Miao Y, Ding LX, Li BS, Shen SH, Liu SL, Li H, Zhu ZQ, Chen HW, Tang ZH, Chen J, Hong DL, Chen HZ, Duan CW, Zhou BS.

Leukemia. 2019 Oct;33(10):2365-2378. doi: 10.1038/s41375-019-0458-0. Epub 2019 Apr 2.

PMID:
30940905
5.

AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells.

Du L, Yang F, Fang H, Sun H, Chen Y, Xu Y, Li H, Zheng L, Zhou BS.

FASEB J. 2019 Mar;33(3):4525-4537. doi: 10.1096/fj.201801559RR. Epub 2019 Jan 31.

PMID:
30702927
6.

Increase of PRPP enhances chemosensitivity of PRPS1 mutant acute lymphoblastic leukemia cells to 5-Fluorouracil.

Wang D, Chen Y, Fang H, Zheng L, Li Y, Yang F, Xu Y, Du L, Zhou BS, Li H.

J Cell Mol Med. 2018 Dec;22(12):6202-6212. doi: 10.1111/jcmm.13907. Epub 2018 Sep 25.

7.

Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.

Tang C, Li MH, Chen YL, Sun HY, Liu SL, Zheng WW, Zhang MY, Li H, Fu W, Zhang WJ, Liang AB, Tang ZH, Hong DL, Zhou BS, Duan CW.

J Exp Clin Cancer Res. 2018 Aug 29;37(1):204. doi: 10.1186/s13046-018-0859-3.

8.

A review of documents prepared by international organizations about influenza pandemics, including the 2009 pandemic: a bibliometric analysis.

Liang F, Guan P, Wu W, Liu J, Zhang N, Zhou BS, Huang DS.

BMC Infect Dis. 2018 Aug 8;18(1):383. doi: 10.1186/s12879-018-3286-3. Review.

9.

The Risk Factors of Acquiring Severe Hand, Foot, and Mouth Disease: A Meta-Analysis.

Sun BJ, Chen HJ, Chen Y, An XD, Zhou BS.

Can J Infect Dis Med Microbiol. 2018 Jun 26;2018:2751457. doi: 10.1155/2018/2751457. eCollection 2018. Review.

10.

Dual-specificity phosphatase 6 genetic variants associated with risk of lung squamous cell carcinoma in Han Chinese.

Wang TL, Song YQ, Ren YW, Zhou BS, Wang HT, Gao Y, Yu H, Zhao YX.

J Cancer Res Ther. 2018;14(Supplement):S72-S78. doi: 10.4103/0973-1482.172108.

11.

HPRT1 activity loss is associated with resistance to thiopurine in ALL.

Yang F, Fang H, Wang D, Chen Y, Zhai Y, Zhou BS, Li H.

Oncotarget. 2017 Dec 19;9(2):2268-2278. doi: 10.18632/oncotarget.23405. eCollection 2018 Jan 5.

12.

Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.

Jia ZF, Wu YH, Cao DH, Cao XY, Jiang J, Zhou BS.

Future Oncol. 2017 May;13(11):979-989. doi: 10.2217/fon-2017-0019. Epub 2017 Feb 24.

PMID:
28326835
13.

Interaction between Helicobacter pylori and host genetic variants in gastric carcinogenesis.

Jia ZF, Zhang SL, Cao XY, Zhou BS, Jiang J.

Future Oncol. 2016 Sep;12(18):2127-34. doi: 10.2217/fon-2016-0233. Epub 2016 Jun 21. Review.

14.

Dual Specificity Phosphatase 6 (DUSP6) Polymorphism Predicts Prognosis of Inoperable Non-Small Cell Lung Cancer after Chemoradiotherapy.

Wang TL, Song YQ, Ren YW, Zhou BS, Wang HT, Bai L, Zhang HB, Yu H, Zhao YX.

Clin Lab. 2016;62(3):301-10.

PMID:
27156317
15.

Euphorbia fischeriana Steud inhibits malignant melanoma via modulation of the phosphoinositide-3-kinase/Akt signaling pathway.

Dong MH, Zhang Q, Wang YY, Zhou BS, Sun YF, Fu Q.

Exp Ther Med. 2016 Apr;11(4):1475-1480. Epub 2016 Feb 9.

16.

CD24 genetic variants contribute to overall survival in patients with gastric cancer.

Jia ZF, Wang LZ, Cao XY, Wang C, Cao DH, Wu X, You LL, Jin MS, Wang YP, Zhou BS, Jiang J.

World J Gastroenterol. 2016 Feb 21;22(7):2373-82. doi: 10.3748/wjg.v22.i7.2373.

17.

Prognostic significance of distal subtotal gastrectomy with standard D2 and extended D2 lymphadenectomy for locally advanced gastric cancer.

Zhang CD, Shen MY, Zhang JK, Ning FL, Zhou BS, Dai DQ.

Sci Rep. 2015 Nov 25;5:17273. doi: 10.1038/srep17273.

18.

The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis.

Xia LZ, Yin ZH, Ren YW, Shen L, Wu W, Li XL, Guan P, Zhou BS.

Springerplus. 2015 Apr 15;4:179. doi: 10.1186/s40064-015-0941-7. eCollection 2015.

19.
20.

Polymorphisms of TERT and CLPTM1L and the risk of hepatocellular carcinoma in Chinese males.

Su LY, Li XL, Shen L, Zhang Y, Zhao MM, Yin ZH, Su HY, Zhou BS.

Asian Pac J Cancer Prev. 2014;15(19):8197-201.

21.

PARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer.

Wang HT, Gao Y, Zhao YX, Yu H, Wang TL, Bai L, Chen YZ, Zhang HB, Zhou BS, Qu YL, Liu D, Chen Y.

Genet Test Mol Biomarkers. 2014 Nov;18(11):736-40. doi: 10.1089/gtmb.2014.0106. Epub 2014 Sep 16.

PMID:
25225750
22.

N-acetyltransferase 2 gene polymorphisms are associated with susceptibility to cancer: a meta-analysis.

Tian FS, Shen L, Ren YW, Zhang Y, Yin ZH, Zhou BS.

Asian Pac J Cancer Prev. 2014;15(14):5621-6.

23.

Health economics evaluation of a gastric cancer early detection and treatment program in China.

Li D, Yuan Y, Sun LP, Fang X, Zhou BS.

Asian Pac J Cancer Prev. 2014;15(13):5133-6.

24.

Single-nucleotide polymorphisms of LIG1 associated with risk of lung cancer.

Chen YZ, Fan ZH, Zhao YX, Bai L, Zhou BS, Zhang HB, Liu D.

Tumour Biol. 2014 Sep;35(9):9229-32. doi: 10.1007/s13277-014-2199-z. Epub 2014 Jun 16. Retraction in: Chen YZ, Fan ZH, Zhao YX, Bai L, Zhou BS, Zhang HB, Liu D. Tumour Biol. 2015 Aug;36(9):7313.

PMID:
24929328
25.

Tagging SNPs in the MTHFR gene and risk of ischemic stroke in a Chinese population.

Zhou BS, Bu GY, Li M, Chang BG, Zhou YP.

Int J Mol Sci. 2014 May 20;15(5):8931-40. doi: 10.3390/ijms15058931.

26.

Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population.

Zhao MM, Zhang Y, Shen L, Ren YW, Li XL, Yin ZH, Zhou BS.

Asian Pac J Cancer Prev. 2014;15(6):2809-13.

27.
28.

TP63 gene polymorphisms, cooking oil fume exposure and risk of lung adenocarcinoma in Chinese non-smoking females.

Yin ZH, Cui ZG, Ren YW, Su M, Ma R, He QC, Zhou BS.

Asian Pac J Cancer Prev. 2014 Jan;14(11):6519-22.

29.
30.

Source identification through social networks in an epidemiological investigation of a hepatitis A outbreak at an elementary school in Anhui province, China.

Wu JB, Li XL, Zhang J, Xu D, Zhu JJ, Zhou BS.

Epidemiol Infect. 2014 Jul;142(7):1450-8. doi: 10.1017/S0950268813002331. Epub 2013 Sep 19.

PMID:
24047565
31.

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors.

Mortazavi A, Ling Y, Martin LK, Wei L, Phelps MA, Liu Z, Harper EJ, Ivy SP, Wu X, Zhou BS, Liu X, Deam D, Monk JP, Hicks WJ, Yen Y, Otterson GA, Grever MR, Bekaii-Saab T.

Invest New Drugs. 2013 Jun;31(3):685-95. doi: 10.1007/s10637-012-9863-1. Epub 2012 Jul 31.

32.

A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancer.

Martin LK, Grecula J, Jia G, Wei L, Yang X, Otterson GA, Wu X, Harper E, Kefauver C, Zhou BS, Yen Y, Bloomston M, Knopp M, Ivy SP, Grever M, Bekaii-Saab T.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e475-81. doi: 10.1016/j.ijrobp.2012.06.003. Epub 2012 Jul 17.

33.

γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers.

Fu S, Yang Y, Das TK, Yen Y, Zhou BS, Zhou MM, Ohlmeyer M, Ko EC, Cagan R, Rosenstein BS, Chen SH, Kao J.

PLoS One. 2012;7(6):e38465. doi: 10.1371/journal.pone.0038465. Epub 2012 Jun 29. Erratum in: PLoS One. 2012;7(9). doi:10.1371/annotation/0d7595f1-c719-4ed9-bef0-8308f4cac7e3. Tirtha, Das [corrected to Das, Tirtha K].

34.

Association between ATM polymorphisms and cancer risk: a meta-analysis.

Shen L, Yin ZH, Wan Y, Zhang Y, Li K, Zhou BS.

Mol Biol Rep. 2012 May;39(5):5719-25. doi: 10.1007/s11033-011-1381-2. Epub 2011 Dec 28.

PMID:
22203481
36.

SULT1A1 Arg213His polymorphism and susceptibility of environment-related cancers: a meta analysis of 5,915 cases and 7,900 controls.

Li K, Ren YW, Wan Y, Yin ZH, Wu W, Zhou BS.

Mol Biol Rep. 2012 Mar;39(3):2597-605. doi: 10.1007/s11033-011-1012-y. Epub 2011 Jun 14.

PMID:
21670965
37.

Health economic assessment for screening of gastric cancer in a high risk population in northeastern china.

Zhou L, Guan P, Sun LP, He QC, Yuan Y, Zhou BS.

Chin J Cancer Res. 2011 Mar;23(1):21-4. doi: 10.1007/s11670-011-0021-7.

38.

NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and the risk of lung cancer: A meta-analysis.

Li C, Yin ZH, Guan P, Li XL, Zhou BS.

Thorac Cancer. 2010 Sep;1(3):102-108. doi: 10.1111/j.1759-7714.2010.00018.x.

39.

Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China.

Liu Z, Su M, Yu SC, Yin ZH, Zhou BS.

Thorac Cancer. 2010 Sep;1(3):126-129. doi: 10.1111/j.1759-7714.2010.00021.x.

40.

Chemo-radiotherapy for advanced non-small cell lung cancer: concurrent or sequential? It's no longer the question: a systematic review.

Liang HY, Zhou H, Li XL, Yin ZH, Guan P, Zhou BS.

Int J Cancer. 2010 Aug 1;127(3):718-28. doi: 10.1002/ijc.25087. Review.

41.

Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review.

Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, Zhou BS.

Int J Cancer. 2009 Dec 15;125(12):2936-44. doi: 10.1002/ijc.24636. Review.

42.

GIS-based spatial, temporal, and space-time analysis of haemorrhagic fever with renal syndrome.

Wu W, Guo JQ, Yin ZH, Wang P, Zhou BS.

Epidemiol Infect. 2009 Dec;137(12):1766-75. doi: 10.1017/S0950268809002659. Epub 2009 Apr 27.

PMID:
19393118
43.

Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapy.

Xiao GG, Zhou BS, Somlo G, Portnow J, Juhasz A, Un F, Chew H, Gandara D, Yen Y.

Cancer Genomics Proteomics. 2008 May-Aug;5(3-4):151-60. Erratum in: Cancer Genomics Proteomics. 2010 May-Jun;7(3):171. Cancer Genomics Proteomics. 2010 Nov-Dec;7(6):365.

44.

[Determining the risk factors of uterine myomas by using back propagation neural network].

Wang W, Xu W, Zhou BS.

Zhonghua Yu Fang Yi Xue Za Zhi. 2007 Jun;41 Suppl:94-7. Chinese.

PMID:
17767869
45.

[Meta-analysis on relationship between FasL and gastric cancer].

Wu W, Guan P, Yuan Y, Zhou BS.

Zhonghua Yu Fang Yi Xue Za Zhi. 2007 Jun;41 Suppl:25-9. Chinese.

PMID:
17767853
46.

[Study on a back propogation neural network-based predictive model for prevalence of birth defect].

Wang W, Xu W, Zheng YJ, Zhou BS.

Zhonghua Liu Xing Bing Xue Za Zhi. 2007 May;28(5):507-9. Chinese.

PMID:
17877186
47.

Perfluorinated compounds in the Pearl River and Yangtze River of China.

So MK, Miyake Y, Yeung WY, Ho YM, Taniyasu S, Rostkowski P, Yamashita N, Zhou BS, Shi XJ, Wang JX, Giesy JP, Yu H, Lam PK.

Chemosphere. 2007 Aug;68(11):2085-95. Epub 2007 Mar 21.

PMID:
17368725
48.
49.

[Study on health economics regarding the screening of gastric cancer in Zhuanghe high risk area].

Pan S, He QC, Zhou BS, Yuan Y.

Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Oct;26(10):757-60. Chinese.

PMID:
16536299
50.

Effects of hexachlorobenzene on antioxidant status of liver and brain of common carp (Cyprinus carpio).

Song SB, Xu Y, Zhou BS.

Chemosphere. 2006 Oct;65(4):699-706. Epub 2006 Feb 23.

PMID:
16497358

Supplemental Content

Support Center